Literature DB >> 18564137

Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression.

Naoki Itano1, Lisheng Zhuo, Koji Kimata.   

Abstract

Hyaluronan acts as a microenvironmental stimulus that can influence the malignant phenotype of cancer cells. During cancer progression, hyaluronan assembles an extracellular matrix that is favorable for both the motility and proliferation of cancer cells and the recruitment of inflammatory and bone marrow-derived progenitor cells. The varied roles of this polysaccharide are regulated via multiple mechanisms involving biosynthesis, degradation, binding with other extracellular molecules, and activation of signaling pathways. Recent animal studies have provided evidence that aberrant biosynthesis of hyaluronan accelerates tumor growth through a diverse repertoire of host-tumor interactions, such as stromal cell recruitment, angiogenesis, lymphangiogenesis, and inflammation. Hyaluronan in the tumor microenvironment thus significantly impacts cancer initiation and progression via stroma-cancer cell interactions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18564137     DOI: 10.1111/j.1349-7006.2008.00885.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  59 in total

Review 1.  Future directions in the field of endometrial cancer research: the need to investigate the tumor microenvironment.

Authors:  A S Felix; J Weissfeld; R Edwards; F Linkov
Journal:  Eur J Gynaecol Oncol       Date:  2010       Impact factor: 0.196

2.  Chronic UVR causes increased immunostaining of CD44 and accumulation of hyaluronan in mouse epidermis.

Authors:  Hanna Siiskonen; Kari Törrönen; Timo Kumlin; Kirsi Rilla; Markku I Tammi; Raija H Tammi
Journal:  J Histochem Cytochem       Date:  2011-08-10       Impact factor: 2.479

3.  Caution should be used in long-term treatment with oral compounds of hyaluronic acid in patients with a history of cancer.

Authors:  Procopio Simone; Migliore Alberto
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

4.  Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1).

Authors:  Berit Bernert; Helena Porsch; Paraskevi Heldin
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

5.  Transactivation of the receptor-tyrosine kinase ephrin receptor A2 is required for the low molecular weight hyaluronan-mediated angiogenesis that is implicated in tumor progression.

Authors:  Frances E Lennon; Tamara Mirzapoiazova; Nurbek Mambetsariev; Bolot Mambetsariev; Ravi Salgia; Patrick A Singleton
Journal:  J Biol Chem       Date:  2014-07-14       Impact factor: 5.157

6.  Chemokines and Cancer Progression: A Qualitative Review on the Role of Stromal Cell-derived Factor 1-alpha and CXCR4 in Endometrial Cancer.

Authors:  Ashley S Felix; Robert Edwards; Robert Bowser; Faina Linkov
Journal:  Cancer Microenviron       Date:  2010-02-26

7.  The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma.

Authors:  Teresa M DesRochers; Yulia Shamis; Addy Alt-Holland; Yasusei Kudo; Takashi Takata; Guangwen Wang; Laurie Jackson-Grusby; Jonathan A Garlick
Journal:  Epigenetics       Date:  2012-01-01       Impact factor: 4.528

8.  Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions.

Authors:  Aarash Bordbar; Nathan E Lewis; Jan Schellenberger; Bernhard Ø Palsson; Neema Jamshidi
Journal:  Mol Syst Biol       Date:  2010-10-19       Impact factor: 11.429

Review 9.  Proteoglycans and their roles in brain cancer.

Authors:  Anna Wade; Aaron E Robinson; Jane R Engler; Claudia Petritsch; C David James; Joanna J Phillips
Journal:  FEBS J       Date:  2013-02-06       Impact factor: 5.542

10.  Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages.

Authors:  Chayanon Ngambenjawong; Maryelise Cieslewicz; Joan G Schellinger; Suzie H Pun
Journal:  J Control Release       Date:  2016-01-07       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.